Health Dictionary Find a Doctor

Benign paroxysmal positional vertigo

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Synonyms and keywords:

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

BPPV was first dicribed by Adler and Barany, who described it as a problem in the otolith organs. In 1952, Margaret Dix and Charles Hallpike named it positional nystagmus of the benign positional type and noticed nystagmus and vertigo with different headmovements. It is understood that BPPV is the result of free floating calcium carbonate crystal formation (canalolithiasis) inside the semicircular canals and Movement of these otoconia with head movement will result in inappropriate stimulation of hair cells following movement of the endolymph. According to which semicircular canal the otoconia have migrated to into 3 subtypes including posterior semicircular canal BPPV, lateral semicircular canal BPPV, and superior (anterior) semicircular canal BPPV. Common causes of BPPV may include age related degeneration of the vestibular system, and head trauma. The diagnostic study of choice for BPPV is patient history and observing nystagmus on Dix-Hall pike maneuver and in most of the cases treatment is Epley maneuver.

Historical Perspective

BPPV was first dicribed by Adler and Barany, who described it as a problem in the otolith organs. In 1952, Margaret Dix and Charles Hallpike named it positional nystagmus of the benign positional type. They noted nystagmus and vertigo with different headmovements. Hallpike also defined it as a peripheral problem rather than central (brain) problem. In 1962 Harold Schuknecht described theory of detached utricular otoconia (cupulolithiasis). Hall et al and Epley described the theory of free floating particle (canalithiasis). The first treatment strategy suggested for BPPV treatment was cawthorne’s exercise (repeatitive head movement which cause vertigo in order to reach central adaption). The newest treatment strategy is to perform Dix Hallpike test to diagnos and induce the vertigo and then performing CRP (Epley) maneuver.

Classification

Benign paroxysmal positional vertigo may be classified according to which semicircular canal the otoconia have migrated to into 3 subtypes including posterior semicircular canal BPPV, lateral semicircular canal BPPV, and superior (anterior) semicircular canal BPPV.

Pathophysiology

It is understood that BPPV is the result of free floating calcium carbonate crystal formation (canalolithiasis) inside the semicircular canals. Movement of these otoconia with head movement will result in inappropriate stimulation of hair cells following movement of the endolymph. In some studies it was demonstrated that people with BPPV in their first degree family are at more risk of development of the disease themselves. One of the theories behind the familial aspect of BPPV is that these families might have less adhesive gelatinous matrix of the utricular macula which predisposed them to BPPV. On microscopic histopathological analysis, crystals with combination of a gelatinous matrix and calcium carbonate are characteristic findings of otoconia in BPPV.

Causes

Common causes of BPPV may include age related degeneration of the vestibular system, and head trauma. Less common causes of BPPV include ear surgery, and prolong positioning on the back (in dentist chair).

Differentiating benign paroxysmal positional vertigo from Other Diseases

BPPV must be differentiated from other diseases that cause vertigo, nystagmus, and hearing problems, such as vestibular neuritis, HSV oticus, Meniere disease, labyrinrhine concussion, perilymphatic fistula, semicircular canal dehiscence syndrome, vestibular paroxysmia, Cogan syndrome, vestibular schwannoma, otitis media, aminoglycoside toxicity, recurrent vestibulopathy, vestibular migraine, epileptic vertigo, multiple sclerosis, brain tumors, cerebellar infarction/hemorrhage, brain stem ischemia, chiari malformation, and Parkinson.

Epidemiology and Demographics

The incidence of BPPV is approximately 107 cases per 100,000 individuals worldwide. The prevalence of BPPV is approximately 65 per 100,000 individuals worldwide. Idiopathic BPPV commonly affects individuals older than 50 years of age. BPPV following head trauma can happen in younger ages. women are more commonly affected by BPPV than men. The women to men ratio is approximately 2 to 1.

Risk Factors

Common risk factors in the development of BPPV include hyperlipidemia, hypertension, smoking, diabetes mellitus, thyroid dysfunction, general anesthesia, advanced age, female gender, and yoga.

Screening

There is insufficient evidence to recommend routine screening for BPPV.

Natural History, Complications, and Prognosis

If left untreated, almost 100% of patients with BPPV may experience spontaneous recovery. Common complications of BPPV include nausea, vomiting, fainting, canal conversion, and cervical spine and neurological complications following Dix Hallpike or Epley maneuvers. Prognosis is generally excellent, and almost always BPPV will resolve over days to weeks on its own even without maneuvers or medications.

Diagnosis

Diagnostic Study of Choice

The diagnostic study of choice for BPPV is patient history and observing nystagmus on Dix-Hall pike maneuver.

History and Symptoms

The hallmark of BPPV is recurrent brief positional vertigo. A positive history of hyperlipidemia, hypertension, smoking, diabetes mellitus, thyroid dysfunction, general anesthesia, advanced age, female gender, and yoga is suggestive of BPPV. The most common symptoms of BPPV include positional vertigo, imbalance, nausea and vomiting.

Physical Examination

Physical examination of patients with BPPV is usually remarkable for balance problems and nystagmus on Dix-Hall pike maneuver.

Laboratory Findings

There are no diagnostic laboratory findings associated with BPPV.

Electrocardiogram

There are no ECG findings associated with BPPV.

X-ray

There are no x-ray findings associated with BPPV.

Echocardiography and Ultrasound

There are no echocardiography/ultrasound findings associated with BPPV.

CT scan

There are no CT scan findings associated with BPPV, but If patients doesn’t respond to treatment or doesn’t show the typical nystagmus on Dix-Hall pike maneuver, we may use CT scan in order to rule out other abnormalities.

MRI

There are no MRI findings associated with BPPV, but If patients doesn’t respond to treatment or doesn’t show the typical nystagmus on Dix-Hall pike maneuver, we may use MRI in order to rule out other abnormalities.

Other Imaging Findings

There are no other imaging findings associated with BPPV.

Other Diagnostic Studies

There are no other diagnostic studies associated with BPPV, but If patients doesn’t respond to treatment or doesn’t show the typical nystagmus on Dix-Hall pike maneuver, in order to rule out other abnormalities we may perform some additional test such as electronystagmography (ENG) or video nystagmography (VNG) and audiometry.

Treatment

Medical Therapy

Pharmacologic medical therapy is recommended among BPPV patients who does not answer well to Epley maneuver and continue to have multiple vertigo attacks which reduces their quality of life. Preferred regimen Betahistine 24 mg PO q12h for 7 days.

Interventions

The mainstay of treatment for BPPV is office maneuvers. For posterior canal BPPV we perform Epley maneuver or Semon maneuver. For horizental canal BPPV we perform Lempert roll maneuver. For superior canal BPPV we perform Epley maneuver.

Surgery

Surgery is not the first-line treatment option for patients with BPPV. Surgery is usually reserved for patients with refractory BPPV. The surgery options include transection of the posterior ampullary nerve, argon laser (inducing ossification of the posterior canal) and surgical occlusion of the posterior canal with bony plugs. Since hearing loss is one of the most important complications of these procedures, hearing problem in the other ear is contraindication for surgery.

Primary Prevention

Effective measures for the primary prevention of BPPV is preventing the modifiable risk factors from happening such as hyperlipidemia, hypertension, smoking, diabetes mellitus, general anesthesia, and yoga.

Secondary Prevention

There are no established measures for the secondary prevention of BPPV.

References


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

BPPV was first dicribed by Adler and Barany, who described it as a problem in the otolith organs. In 1952, Margaret Dix and Charles Hallpike named it positional nystagmus of the benign positional type. They noted nystagmus and vertigo with different head movements. Hallpike also defined it as a peripheral problem rather than central (brain) problem. In 1962 Harold Schuknecht described theory of detached utricular otoconia (cupulolithiasis). Hall et al and Epley described the theory of free floating particle (canalithiasis). The first treatment strategy suggested for BPPV treatment was cawthorne’s exercise (repeatitive head movement which cause vertigo in order to reach central adaption). The newest treatment strategy is to perform Dix Hallpike test to diagnos and induce the vertigo and then performing CRP (Epley) maneuver.

Historical Perspective

Discovery

  • In 1952, Margaret Dix and Charles Hallpike named it positional nystagmus of the benign positional type.
  • They noted nystagmus and vertigo with different head movements.
  • Hallpike also defined it as a peripheral problem rather than central (brain) problem.
  • In 1824 Marie-Jean Flourens concluded that semicircular canals are not a hearing organ but a balance-related organ.
  • In 1962 Harold Schuknecht described theory of detached utricular otoconia (cupulolithiasis).
  • Hall et al and Epley described the theory of free floating particle (canalithiasis).

Landmark Events in the Development of Treatment Strategies

  • The first treatment strategy suggested for BPPV treatment was cawthorne’s exercise (repeatitive head movement which cause vertigo in order to reach central adaption).[5][6][7][8]
  • Brandt and Daroff suggested a maneuver consisting of laying down on each side for 30 seconds.
  • Semont and Sterkes described liberatory maneuver (semont maneuver). In this maneuver patient lays down to the provocative side looking downward. When nystagmus stops the doctor should rapidly moved the patient head 90 degree on the other side.
  • The newest treatment strategy is to perform Dix Hallpike test to diagnose and induce the vertigo and then performing CRP (Epley) maneuver.

For more information about Dix Hallpike maneuvers, click here.

For more information about Epley maneuvers, click here.

Famous Cases

The following are a few famous cases of BPPV:

  • Arthur Black, writer and former CBC radio host
  • Lebron James, NBA
  • Crown Princess Mette-Marit of Norway

References

  1. DIX MR, HALLPIKE CS (December 1952). “The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system”. Ann. Otol. Rhinol. Laryngol. 61 (4): 987–1016. doi:10.1177/000348945206100403. PMID 13008328.
  2. SCHUKNECHT HF (1962). “Positional vertigo: clinical and experimental observations”. Trans Am Acad Ophthalmol Otolaryngol. 66: 319–32. PMID 13909445.
  3. Hall SF, Ruby RR, McClure JA (April 1979). “The mechanics of benign paroxysmal vertigo”. J Otolaryngol. 8 (2): 151–8. PMID 430582.
  4. Flourens, P., 1824. Recherches sur les conditions fondamentales de l’audition. Memoires de la Société (Royale) des Sciences.
  5. Brandt T, Daroff RB (August 1980). “Physical therapy for benign paroxysmal positional vertigo”. Arch Otolaryngol. 106 (8): 484–5. PMID 7396795.
  6. Semont A, Freyss G, Vitte E (1988). “Curing the BPPV with a liberatory maneuver”. Adv. Otorhinolaryngol. 42: 290–3. PMID 3213745.
  7. Viirre, Erik; Purcell, Ian; Baloh, Robert W. (2005). “The Dix-Hallpike Test and The Canalith Repositioning Maneuver”. The Laryngoscope. 115 (1): 184–187. doi:10.1097/01.mlg.0000150707.66569.d4. ISSN 0023-852X.
  8. Ruckenstein, Michael J. (2001). “Therapeutic Efficacy of the Epley Canalith Repositioning Maneuver”. The Laryngoscope. 111 (6): 940–945. doi:10.1097/00005537-200106000-00003. ISSN 0023-852X.

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Benign paroxysmal positional vertigo may be classified according to which semicircular canal the otoconia have migrated to into 3 subtypes including posterior semicircular canal BPPV, lateral semicircular canal BPPV, and superior (anterior) semicircular canal BPPV.

Classification

Benign paroxysmal positional vertigo may be classified according to which semicircular canal the otoconia have migrated to into 3 subtypes:[1]

    References

    1. Nuti D, Masini M, Mandalà M (2016). “Benign paroxysmal positional vertigo and its variants”. Handb Clin Neurol. 137: 241–56. doi:10.1016/B978-0-444-63437-5.00018-2. PMID 27638076.

    Template:WH Template:WS

    Pathophysiology

    Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

    Overview

    It is understood that BPPV is the result of free floating calcium carbonate crystal formation (canalolithiasis) inside the semicircular canals. Movement of these otoconia with head movement will result in inappropriate stimulation of hair cells following movement of the endolymph. In some studies it was demonstrated that people with BPPV in their first degree family are at more risk of development of the disease themselves. One of the theories behind the familial aspect of BPPV is that these families might have less adhesive gelatinous matrix of the utricular macula which predisposed them to BPPV. On microscopic histopathological analysis, crystals with combination of a gelatinous matrix and calcium carbonate are characteristic findings of otoconia in BPPV.

    Pathophysiology

    https://en.wikipedia.org/wiki/File:Blausen_0329_EarAnatomy_InternalEar.png
    https://en.wikipedia.org/wiki/File:Vestibular_system%27s_semicircular_canal-_a_cross-section.jpg

    Physiology

    The normal physiology of semicircular canals can be understood as follows:[1]

    Pathogenesis

      Genetics

      • The development of idiopathic BPPV may be the result of multiple genetic mutations.[3][4]
      • In some studies it was demonstrated that people with BPPV in their first degree family are at more risk of development of the disease themselves.
      • One of the theories behind the familial aspect of BPPV is that these families might have less adhesive gelatinous matrix of the utricular macula which predisposed them to BPPV.

      Associated Conditions

      Conditions associated with BPPV include:[5][6]

      Gross Pathology

      • there is no gross pathology findings with BPPV.

      Microscopic Pathology

      References

      1. Chester JB (July 1991). “Whiplash, postural control, and the inner ear”. Spine. 16 (7): 716–20. PMID 1925743.
      2. 2.0 2.1 Hornibrook J (2011). “Benign Paroxysmal Positional Vertigo (BPPV): History, Pathophysiology, Office Treatment and Future Directions”. Int J Otolaryngol. 2011: 835671. doi:10.1155/2011/835671. PMC 3144715. PMID 21808648.
      3. Gizzi M, Ayyagari S, Khattar V (November 1998). “The familial incidence of benign paroxysmal positional vertigo”. Acta Otolaryngol. 118 (6): 774–7. PMID 9870618.
      4. Gizzi MS, Peddareddygari LR, Grewal RP (2015). “A familial form of benign paroxysmal positional vertigo maps to chromosome 15”. Int. J. Neurosci. 125 (8): 593–6. doi:10.3109/00207454.2014.953157. PMID 25135283.
      5. Cohen, Helen S.; Kimball, Kay T.; Stewart, Michael G. (2004). “Benign Paroxysmal Positional Vertigo and Comorbid Conditions”. ORL. 66 (1): 11–15. doi:10.1159/000077227. ISSN 0301-1569.
      6. Chu, Chia-Huei; Liu, Chia-Jen; Lin, Liang-Yu; Chen, Tzeng-Ji; Wang, Shuu-Jiun (2015). “Migraine is associated with an increased risk for benign paroxysmal positional vertigo: a nationwide population-based study”. The Journal of Headache and Pain. 16 (1). doi:10.1186/s10194-015-0547-z. ISSN 1129-2369.

      Template:WH Template:WS

      Causes

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

      Overview

      Common causes of BPPV may include age related degeneration of the vestibular system, and head trauma. Less common causes of BPPV include ear surgery, and prolong positioning on the back (in dentist chair).

      Causes

      Life-threatening Causes

      • There are no life-threatening causes of BPPV.

      Common Causes

      Common causes of BPPV may include:[1][2]

      Less Common Causes

      Less common causes of BPPV include:[3]

      • Ear surgery
      • Prolong positioning on the back (in dentist chair)

      Genetic Causes

      • The development of idiopathic BPPV may be the result of multiple genetic mutations which leads to less adhesive gelatinous matrix of the utricular macula which predisposed them to BPPV.

      Causes by Organ System

      Cardiovascular No underlying causes
      Chemical/Poisoning No underlying causes
      Dental Prolong positioning on the back (in dentist chair)
      Dermatologic No underlying causes
      Drug Side Effect No underlying causes
      Ear Nose Throat Ear surgery/ vestibular abnormalities
      Endocrine No underlying causes
      Environmental No underlying causes
      Gastroenterologic No underlying causes
      Genetic Familial predisposition to BPPV
      Hematologic No underlying causes
      Iatrogenic No underlying causes
      Infectious Disease No underlying causes
      Musculoskeletal/Orthopedic No underlying causes
      Neurologic No underlying causes
      Nutritional/Metabolic No underlying causes
      Obstetric/Gynecologic No underlying causes
      Oncologic No underlying causes
      Ophthalmologic No underlying causes
      Overdose/Toxicity No underlying causes
      Psychiatric No underlying causes
      Pulmonary No underlying causes
      Renal/Electrolyte No underlying causes
      Rheumatology/Immunology/Allergy No underlying causes
      Sexual No underlying causes
      Trauma Head trauma
      Urologic No underlying causes
      Miscellaneous No underlying causes

      Causes in Alphabetical Order

      List the causes of the disease in alphabetical order:

      References

      1. Gordon CR, Joffe V, Levite R, Gadoth N (November 2002). “[Traumatic benign paroxysmal positional vertigo: diagnosis and treatment]”. Harefuah (in Hebrew). 141 (11): 944–7, 1012, 1011. PMID 12476625.
      2. Iwasaki S, Yamasoba T (February 2015). “Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System”. Aging Dis. 6 (1): 38–47. doi:10.14336/AD.2014.0128. PMC 4306472. PMID 25657851.
      3. Chiarella, Giuseppe; Leopardi, Gianluca; De Fazio, Luca; Chiarella, Rosarita; Cassandro, Ettore (2007). “Benign paroxysmal positional vertigo after dental surgery”. European Archives of Oto-Rhino-Laryngology. 265 (1): 119–122. doi:10.1007/s00405-007-0397-7. ISSN 0937-4477.

      Template:WH Template:WS

      Differentiating Benign paroxysmal positional vertigo from other Diseases

      For the WikiDoc page for this topic, click here

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

      Overview

      BPPV must be differentiated from other diseases that cause vertigo, nystagmus, and hearing problems, such as vestibular neuritis, HSV oticus, Meniere disease, labyrinrhine concussion, perilymphatic fistula, semicircular canal dehiscence syndrome, vestibular paroxysmia, Cogan syndrome, vestibular schwannoma, otitis media, aminoglycoside toxicity, recurrent vestibulopathy, vestibular migraine, epileptic vertigo, multiple sclerosis, brain tumors, cerebellar infarction/hemorrhage, brain stem ischemia, chiari malformation, and Parkinson.

      Differentiating BPPV from other Diseases

      BPPV must be differentiated from other diseases that cause vertigo, nystagmus, and hearing problems, such as vestibular neuritis, HSV oticus, Meniere disease, labyrinrhine concussion, perilymphatic fistula, semicircular canal dehiscence syndrome, vestibular paroxysmia, Cogan syndrome, vestibular schwannoma, otitis media, aminoglycoside toxicity, recurrent vestibulopathy, vestibular migraine, epileptic vertigo, multiple sclerosis, brain tumors, cerebellar infarction/hemorrhage, brain stem ischemia, chiari malformation, and Parkinson.

      Differentiating BPPV from other diseases on the basis of vertigo, nystagmus, and hearing problems

      On the basis of vertigo, nystagmus, and hearing problems, BPPV must be differentiated from vestibular neuritis, HSV oticus, Meniere disease, labyrinrhine concussion, perilymphatic fistula, semicircular canal dehiscence syndrome, vestibular paroxysmia, Cogan syndrome, vestibular schwannoma, otitis media, aminoglycoside toxicity, recurrent vestibulopathy, vestibular migraine, epileptic vertigo, multiple sclerosis, brain tumors, cerebellar infarction/hemorrhage, brain stem ischemia, chiari malformation, and Parkinson.

      Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
      Symptoms Physical examination
      Lab Findings Imaging
      Acute onset Recurrency Nystagmus Hearing problems
      Peripheral
      BPPV
      [1][2][3]
      + + +/−
      Vestibular neuritis
      [4]
      + +/− + /−

      (unilateral)

      • + Head thrust test
      HSV oticus
      [5][6][7][8]
      + +/− +/− + VZV antibody titres
      Meniere disease
      [9][10]
      +/− + +/− + (Progressive)
      Labyrinthine concussion
      [11][12]
      + +
      Perilymphatic fistula
      [13][14][15]
      +/− + +
      • CT scan may show fluid around the round window recess
      Semicircular canal

      dehiscence syndrome
      [16][17]

      +/− + +

      (air-bone gaps on audiometry)

      Vestibular paroxysmia
      [18][19][20]
      + + +/−

      (Induced by hyperventilation)

      Cogan syndrome
      [21][22][23]
      + +/− + Increased ESR and cryoglobulins
      • In CT scan we may see calcification or soft tissue attenuation obliterating the intralabyrinthine fluid spaces
      Vestibular schwannoma
      [24][25]
      + +/− +
      Otitis media
      [26][27]
      + +/− Increased acute phase reactants
      Aminoglycoside toxicity
      [28]
      + +
      Recurrent vestibulopathy
      [29][30]
      +
      • It may happen infrequently, every one to two years
      • It may be associated with nausea and vomiting
      • It may overlap with vestibular migraine
      Central
      Vestibular migrain
      [31][32]
      + +/− +/−
      • ICHD-3 criteria
      Epileptic vertigo
      [33]
      + +/−
      • They response well to anti-seizure drugs
      Multiple sclerosis
      [34][35][36]
      + +/− Elevated concentration of CSF oligoclonal bands
      • MS is at least two times more common among women than men
      • The onset of symptoms is mostly between the age of fifteen to forty years, rarely before age fifteen or after age sixty
      Brain tumors
      [37]
      +/− + + + Cerebral spinal fluid (CSF) may show cancerous cells
      • On CT scan most of the brain tumors appears as a hypodense mass lesions
      • On MRI most of the brain tumors appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI.
      Cerebellar infarction/hemorrhage + ++/−
      • Based on the time interval between stroke and imaging we may have different presentations
      Brain stem ischemia + +/−
      • Based on the time interval between stroke and imaging we may have different presentations
      • For more information click here
      Chiari malformation
      [38][39]
      + +
      • Patient may experience ringing in the ears
      Parkinson
      [40][41][42]
      +

      ABBREVIATIONS

      VZV= Varicella zoster virus, MRI= Magnetic resonance imaging, ESR= Erythrocyte sedimentation rate, EEG= Electroencephalogram, CSF= Cerebrospinal fluid, GPe= Globus pallidus externa, ICHD= International Classification of Headache Disorders

      References

      1. Lee SH, Kim JS (June 2010). “Benign paroxysmal positional vertigo”. J Clin Neurol. 6 (2): 51–63. doi:10.3988/jcn.2010.6.2.51. PMC 2895225. PMID 20607044.
      2. Chang MB, Bath AP, Rutka JA (October 2001). “Are all atypical positional nystagmus patterns reflective of central pathology?”. J Otolaryngol. 30 (5): 280–2. PMID 11771020.
      3. Dorresteijn PM, Ipenburg NA, Murphy KJ, Smit M, van Vulpen JK, Wegner I, Stegeman I, Grolman W (June 2014). “Rapid Systematic Review of Normal Audiometry Results as a Predictor for Benign Paroxysmal Positional Vertigo”. Otolaryngol Head Neck Surg. 150 (6): 919–24. doi:10.1177/0194599814527233. PMID 24642523.
      4. Mandalà M, Nuti D, Broman AT, Zee DS (February 2008). “Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis”. Arch. Otolaryngol. Head Neck Surg. 134 (2): 164–9. doi:10.1001/archoto.2007.35. PMID 18283159.
      5. Wackym, Phillip A. (1997). “Molecular Temporal Bone Pathology: II. Ramsay Hunt Syndrome (Herpes Zoster Oticus)”. The Laryngoscope. 107 (9): 1165–1175. doi:10.1097/00005537-199709000-00003. ISSN 0023-852X.
      6. Zhu, S.; Pyatkevich, Y. (2014). “Ramsay Hunt syndrome type II”. Neurology. 82 (18): 1664–1664. doi:10.1212/WNL.0000000000000388. ISSN 0028-3878.
      7. Mishell JH, Applebaum EL (February 1990). “Ramsay-Hunt syndrome in a patient with HIV infection”. Otolaryngol Head Neck Surg. 102 (2): 177–9. doi:10.1177/019459989010200215. PMID 2113244.
      8. Tada, Yuichiro; Aoyagi, Masaru; Tojima, Hitoshi; Inamura, Hiroo; Saito, Osamu; Maeyama, Hiroyuki; Kohsyu, Hidehiro; Koike, Yoshio (2009). “Gd-DTPA Enhanced MRI in Ramsay Hunt Syndrome”. Acta Oto-Laryngologica. 114 (sup511): 170–174. doi:10.3109/00016489409128326. ISSN 0001-6489.
      9. Watanabe, Isamu (1980). “Ménière’s Disease”. ORL. 42 (1–2): 20–45. doi:10.1159/000275477. ISSN 1423-0275.
      10. Saeed SR (January 1998). “Fortnightly review. Diagnosis and treatment of Ménière’s disease”. BMJ. 316 (7128): 368–72. PMC 2665527. PMID 9487176.
      11. Dürrer, J.; Poláčková, J. (1971). “Labyrinthine Concussion”. ORL. 33 (3): 185–190. doi:10.1159/000274994. ISSN 1423-0275.
      12. Choi MS, Shin SO, Yeon JY, Choi YS, Kim J, Park SK (April 2013). “Clinical characteristics of labyrinthine concussion”. Korean J Audiol. 17 (1): 13–7. doi:10.7874/kja.2013.17.1.13. PMC 3936518. PMID 24653897.
      13. Fox, Eileen J.; Balkany, Thomas J.; Arenberg, Kaufman (1988). “The Tullio Phenomenon and Perilymph Fistula”. Otolaryngology–Head and Neck Surgery. 98 (1): 88–89. doi:10.1177/019459988809800115. ISSN 0194-5998.
      14. Casselman JW (February 2002). “Diagnostic imaging in clinical neuro-otology”. Curr. Opin. Neurol. 15 (1): 23–30. PMID 11796947.
      15. Seltzer S, McCabe BF (January 1986). “Perilymph fistula: the Iowa experience”. Laryngoscope. 96 (1): 37–49. PMID 3941579.
      16. Lempert T, von Brevern M (February 2005). “Episodic vertigo”. Curr. Opin. Neurol. 18 (1): 5–9. PMID 15655395.
      17. Watson SR, Halmagyi GM, Colebatch JG (February 2000). “Vestibular hypersensitivity to sound (Tullio phenomenon): structural and functional assessment”. Neurology. 54 (3): 722–8. PMID 10680810.
      18. Hufner, K.; Barresi, D.; Glaser, M.; Linn, J.; Adrion, C.; Mansmann, U.; Brandt, T.; Strupp, M. (2008). “Vestibular paroxysmia: Diagnostic features and medical treatment”. Neurology. 71 (13): 1006–1014. doi:10.1212/01.wnl.0000326594.91291.f8. ISSN 0028-3878.
      19. Strupp M, von Stuckrad-Barre S, Brandt T, Tonn JC (February 2013). “Teaching neuroimages: Compression of the eighth cranial nerve causes vestibular paroxysmia”. Neurology. 80 (7): e77. doi:10.1212/WNL.0b013e318281cc2c. PMID 23400324.
      20. Hüfner K, Barresi D, Glaser M, Linn J, Adrion C, Mansmann U, Brandt T, Strupp M (September 2008). “Vestibular paroxysmia: diagnostic features and medical treatment”. Neurology. 71 (13): 1006–14. doi:10.1212/01.wnl.0000326594.91291.f8. PMID 18809837.
      21. Vollertsen RS (May 1990). “Vasculitis and Cogan’s syndrome”. Rheum. Dis. Clin. North Am. 16 (2): 433–9. PMID 2189159.
      22. Hughes, Gordon B.; Kinney, Sam E.; Barna, Barbara P.; Tomsak, Robert L.; Calabrese, Leonard H. (1983). “Autoimmune reactivity in Cogan’s syndrome: A preliminary report”. Otolaryngology–Head and Neck Surgery. 91 (1): 24–32. doi:10.1177/019459988309100106. ISSN 0194-5998.
      23. Majoor, M. H. J. M.; Albers, F. W. J.; Casselman, J. W. (2009). “Clinical Relevance of Magnetic Resonance Imaging and Computed Tomography in Cogan’s Syndrome”. Acta Oto-Laryngologica. 113 (5): 625–631. doi:10.3109/00016489309135875. ISSN 0001-6489.
      24. Robert W. Foley, Shahram Shirazi, Robert M. Maweni, Kay Walsh, Rory McConn Walsh, Mohsen Javadpour & Daniel Rawluk (2017). “Signs and Symptoms of Acoustic Neuroma at Initial Presentation: An Exploratory Analysis”. Cureus. 9 (11): e1846. doi:10.7759/cureus.1846. PMID 29348989. Unknown parameter |month= ignored (help)
      25. E. P. Lin & B. T. Crane (2017). “The Management and Imaging of Vestibular Schwannomas”. AJNR. American journal of neuroradiology. 38 (11): 2034–2043. doi:10.3174/ajnr.A5213. PMID 28546250. Unknown parameter |month= ignored (help)
      26. “Ear infection – acute: MedlinePlus Medical Encyclopedia”.
      27. Rettig E, Tunkel DE (2014). “Contemporary concepts in management of acute otitis media in children”. Otolaryngol. Clin. North Am. 47 (5): 651–72. doi:10.1016/j.otc.2014.06.006. PMC 4393005. PMID 25213276.
      28. Ernfors P, Duan ML, ElShamy WM, Canlon B (April 1996). “Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3”. Nat. Med. 2 (4): 463–7. PMID 8597959.
      29. Oh AK, Lee H, Jen JC, Corona S, Jacobson KM, Baloh RW (May 2001). “Familial benign recurrent vertigo”. Am. J. Med. Genet. 100 (4): 287–91. PMID 11343320.
      30. Rutka JA, Barber HO (April 1986). “Recurrent vestibulopathy: third review”. J Otolaryngol. 15 (2): 105–7. PMID 3712538.
      31. “The International Classification of Headache Disorders: 2nd edition”. Cephalalgia. 24 Suppl 1: 9–160. 2004. PMID 14979299.
      32. Absinta M, Rocca MA, Colombo B, Copetti M, De Feo D, Falini A, Comi G, Filippi M (December 2012). “Patients with migraine do not have MRI-visible cortical lesions”. J. Neurol. 259 (12): 2695–8. doi:10.1007/s00415-012-6571-x. PMID 22714135.
      33. Tarnutzer AA, Lee SH, Robinson KA, Kaplan PW, Newman-Toker DE (April 2015). “Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review”. Neurology. 84 (15): 1595–604. doi:10.1212/WNL.0000000000001474. PMC 4408281. PMID 25795644.
      34. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (July 2001). “Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis”. Ann. Neurol. 50 (1): 121–7. PMID 11456302.
      35. Barrett L, Drayer B, Shin C (January 1985). “High-resolution computed tomography in multiple sclerosis”. Ann. Neurol. 17 (1): 33–8. doi:10.1002/ana.410170109. PMID 3985583.
      36. Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH (August 1999). “The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis”. Neurology. 53 (3): 448–56. PMID 10449103.
      37. Dunniway, Heidi M.; Welling, D. Bradley (2016). “Intracranial Tumors Mimicking Benign Paroxysmal Positional Vertigo”. Otolaryngology–Head and Neck Surgery. 118 (4): 429–436. doi:10.1177/019459989811800401. ISSN 0194-5998.
      38. Caldarelli M, Di Rocco C (May 2004). “Diagnosis of Chiari I malformation and related syringomyelia: radiological and neurophysiological studies”. Childs Nerv Syst. 20 (5): 332–5. doi:10.1007/s00381-003-0880-4. PMID 15034729.
      39. Sarnat HB (2008). “Disorders of segmentation of the neural tube: Chiari malformations”. Handb Clin Neurol. 87: 89–103. doi:10.1016/S0072-9752(07)87006-0. PMID 18809020.
      40. van Wensen, E.; van Leeuwen, R.B.; van der Zaag-Loonen, H.J.; Masius-Olthof, S.; Bloem, B.R. (2013). “Benign paroxysmal positional vertigo in Parkinson’s disease”. Parkinsonism & Related Disorders. 19 (12): 1110–1112. doi:10.1016/j.parkreldis.2013.07.024. ISSN 1353-8020.
      41. Steiner I, Gomori JM, Melamed E (1985). “Features of brain atrophy in Parkinson’s disease. A CT scan study”. Neuroradiology. 27 (2): 158–60. PMID 3990948.
      42. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S (January 2006). “MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease”. J. Neurol. 253 (1): 26–32. doi:10.1007/s00415-005-0914-9. PMID 15981079.

      Template:WH Template:WS

      Epidemiology and Demographics

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

      Overview

      The incidence of BPPV is approximately 107 cases per 100,000 individuals worldwide. The prevalence of BPPV is approximately 65 per 100,000 individuals worldwide. Idiopathic BPPV commonly affects individuals older than 50 years of age. BPPV following head trauma can happen in younger ages. women are more commonly affected by BPPV than men. The women to men ratio is approximately 2 to 1.

      Epidemiology and Demographics

      Incidence

      • The incidence of BPPV is approximately 107 cases per 100,000 individuals worldwide.[1]

      Prevalence

      • The prevalence of BPPV is approximately 65 per 100,000 individuals worldwide.

      Age

      • Idiopathic BPPV commonly affects individuals older than 50 years of age.[2]
      • BPPV following head trauma can happen in younger ages.

      Race

      • There is no racial predilection to BPPV.

      Gender

      • women are more commonly affected by BPPV than men. The women to men ratio is approximately 2 to 1.[3]

      Region

      • There is no region predilection to BPPV.

      References

      1. Froehling DA, Silverstein MD, Mohr DN, Beatty CW, Offord KP, Ballard DJ (June 1991). “Benign positional vertigo: incidence and prognosis in a population-based study in Olmsted County, Minnesota”. Mayo Clin. Proc. 66 (6): 596–601. PMID 2046397.
      2. Baloh RW, Honrubia V, Jacobson K (March 1987). “Benign positional vertigo: clinical and oculographic features in 240 cases”. Neurology. 37 (3): 371–8. PMID 3822129.
      3. von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, Neuhauser H (July 2007). “Epidemiology of benign paroxysmal positional vertigo: a population based study”. J. Neurol. Neurosurg. Psychiatry. 78 (7): 710–5. doi:10.1136/jnnp.2006.100420. PMC 2117684. PMID 17135456.

      Template:WH Template:WS

      Risk Factors

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

      Overview

      Common risk factors in the development of BPPV include hyperlipidemia, hypertension, smoking, diabetes mellitus, thyroid dysfunction, general anesthesia, advanced age, female gender, and yoga.

      Risk Factors

      Common Risk Factors

      Common risk factors in the development of BPPV include:[1][2][3][4]

      Less Common Risk Factors

      Less common risk factors in the development of BPPV include:

      • Ceiling painting
      • Mechanics who spend a lot of time under cars
      • Running on treadmill

      References

      1. Wang CX, Wang JM (September 2018). “[Risk factors for recurrence of benign paroxysmal positional vertigo: a Meta analysis]”. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (in Chinese). 32 (17): 1298–1303. doi:10.13201/j.issn.1001-1781.2018.17.003. PMID 30282182.
      2. von Brevern, M; Radtke, A; Lezius, F; Feldmann, M; Ziese, T; Lempert, T; Neuhauser, H (2006). “Epidemiology of benign paroxysmal positional vertigo: a population based study”. Journal of Neurology, Neurosurgery & Psychiatry. 78 (7): 710–715. doi:10.1136/jnnp.2006.100420. ISSN 0022-3050.
      3. D’Silva, Linda J.; Staecker, Hinrich; Lin, James; Sykes, Kevin J.; Phadnis, Milind A.; McMahon, Tamara M.; Connolly, Dan; Sabus, Carla H.; Whitney, Susan L.; Kluding, Patricia M. (2016). “Retrospective data suggests that the higher prevalence of benign paroxysmal positional vertigo in individuals with type 2 diabetes is mediated by hypertension”. Journal of Vestibular Research. 25 (5–6): 233–239. doi:10.3233/VES-150563. ISSN 0957-4271.
      4. Koçak, İlker (2017). “Can yoga cause benign paroxysmal positional vertigo?”. The Turkish Journal of Ear Nose and Throat. 27 (4): 159–163. doi:10.5606/kbbihtisas.2017.22844. ISSN 1300-7475.

      Template:WH Template:WS

      Screening

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

      Overview

      There is insufficient evidence to recommend routine screening for BPPV.

      Screening

      • There is insufficient evidence to recommend routine screening for BPPV.

      References

      Template:WH Template:WS

      Natural History, Complications and Prognosis

      Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

      Overview

      If left untreated, almost 100% of patients with BPPV may experience spontaneous recovery. Common complications of BPPV include nausea, vomiting, fainting, canal conversion, and cervical spine and neurological complications following Dix Hallpike or Epley maneuvers. Prognosis is generally excellent, and almost always BPPV will resolve over days to weeks on its own even without maneuvers or medications.

      Natural History, Complications, and Prognosis

      Natural History

      • The symptoms of BPPV usually develop after 40-50 years of life start with vertigo that last less than one minute and starts after specific head movements.[1]
      • If left untreated, almost 100% of patients with BPPV may experience spontaneous recovery.[2]

      Complications

      Prognosis

      • Prognosis is generally excellent, and almost always BPPV will resolve over days to weeks on its own even without maneuvers or medications.[2]
      • Resolving of the BPPV which is the result of head trauma or structural abnormalities might take a little more time.
      • Recurrence is common and happens in more than 30% of patients.
      • Patients older than 40 years of age, with horizontal BPPV or post traumatic BPPV are more susceptible to recurrence.

      References

      1. Baloh RW, Honrubia V, Jacobson K (March 1987). “Benign positional vertigo: clinical and oculographic features in 240 cases”. Neurology. 37 (3): 371–8. PMID 3822129.
      2. 2.0 2.1 del Rio, Maria; Arriaga, Moisés A. (2016). “Benign Positional Vertigo: Prognostic Factors”. Otolaryngology-Head and Neck Surgery. 130 (4): 426–429. doi:10.1016/j.otohns.2003.12.015. ISSN 0194-5998.
      3. Bergin M, Bird P, Wright A (May 2010). “Internal carotid artery dissection following canalith repositioning procedure”. J Laryngol Otol. 124 (5): 575–6. doi:10.1017/S0022215109991356. PMID 19785929.
      4. Hughes, C. Anthony; Proctor, Leonard (1997). “Benign Paroxysmal Positional Vertigo”. The Laryngoscope. 107 (5): 607–613. doi:10.1097/00005537-199705000-00010. ISSN 0023-852X.

      Template:WH Template:WS

      Diagnosis

      Diagnosis

      Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

      Treatment

      Treatment

      Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

      Case Studies

      Case Studies

      Case #1

      Looking for the patient version?

      Back to the patient-friendly article

      © 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH